Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 27, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cero Therapeutics Holdings, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 25
| |||||||
Cero Therapeutics Holdings, Inc.
| 248.74K |
—
|
—
|
∞
| 248.74K |
Feb 14
| |||||||
Cero Therapeutics Holdings, Inc.
| 248.74K |
—
|
—
|
∞
| 248.74K |
Feb 14
| |||||||
Cero Therapeutics Holdings, Inc.
| 373.74K |
—
|
—
|
∞
| 373.74K |
Feb 14
| |||||||
Atreca, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Atreca, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Phoenix Biotech Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
|
Oct 8
| |||||||
Phoenix Biotech Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Clovis Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Atreca, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Locust Walk Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
|
Jan 12
| |||||||
Locust Walk Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Atreca, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 9
| |||||||
Clovis Oncology, Inc.
| 6.9K |
$3.08 | $21,239.68 | +26.66% | 32.76K |
Nov 9
| |||||||
Atreca, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Clovis Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 4
| |||||||
Clovis Oncology, Inc.
| 25.86K |
$0.29 | $7,499.98 |
∞
| 25.86K |
Aug 20
| |||||||
Atreca, Inc.
| 8.79K |
—
|
—
| +21.51% | 49.65K |
Jun 24
| |||||||
Atreca, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Clovis Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Clovis Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 11
| |||||||
Clovis Oncology, Inc.
| 5.21K |
—
|
—
| +25.58% | 25.58K |
Jun 26
| |||||||
Clovis Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Phaserx, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 25
| |||||||
Opgen Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Veracyte, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Flexion Therapeutics Inc
| 714.28K |
$14.00 | $9,999,990.00 | +25.35% | 3.53M |
Jun 8
| |||||||
Clovis Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Phaserx, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Glaukos Corp
| -414.16K |
$23.98 | -$816,710.84 | -13.21% | 2.72M |
May 31
| |||||||
Phaserx, Inc.
| 341.96K |
$2.51 | $2,997,419.56 | +21.36% | 1.94M |
May 23
| |||||||
Phaserx, Inc.
| 341.96K |
$2.51 | $2,997,419.56 | +21.36% | 1.94M |
May 23
| |||||||
Phaserx, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Phaserx, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Phaserx, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Phaserx, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Immune Design Corp.
|
0
|
—
|
—
|
—
|
0
|
Jan 4
| |||||||
Glaukos Corp
| 3.14M |
$18.00 | -$229,824.00 |
∞
| 3.14M |
Jun 30
| |||||||
Glaukos Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Five Prime Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 12
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.